NEUROPEPTIDE Y (13-36) (PORCINE)(CAS: 113662-54-7)

NEUROPEPTIDE Y (13-36) (PORCINE) (CAS: 113662-54-7) is regulated under various guidelines including GHS for classification and labelling, REACH for registration, evaluation, authorization, and restriction of chemicals, and FDA/EPA for safety and environmental considerations. Manufacturers and distributors must comply with these regulations to ensure the product is handled safely and legally.

Alternatives to NEUROPEPTIDE Y (13-36) (PORCINE) (CAS: 113662-54-7) in synthesis include analogs such as NEUROPEPTIDE Y (1-36) and isomers. Common alternative reagents like Fmoc chemistry or solid-phase peptide synthesis may also be used to produce similar compounds with slight variations.

The market for NEUROPEPTIDE Y (13-36) (PORCINE) (CAS: 113662-54-7) is growing due to its potential in neurological research and drug development. Research trends include exploring its role in appetite regulation, reducing inflammation, and treating obesity. The increasing focus on personalized medicine and peptide-based therapies is likely to drive further interest in this compound.

Waste containing NEUROPEPTIDE Y (13-36) (PORCINE) (CAS: 113662-54-7) should be collected in appropriate containers and stored in a cool, dry place away from direct sunlight. Incineration or professional waste disposal services are recommended to ensure safe and compliant handling. Environmental protection measures should include minimizing spillages and adhering to local and international waste disposal regulations.